New target identified for preventing bone destruction in diseases such as arthritis and cancer

December 04, 2013

The skeleton is constantly being remodelled by the breakdown of old bone by cells called osteoclasts and the formation of new bone by cells called osteoblasts. This coordinated activity is essential for maintaining healthy bone. However, excessive osteoclast activity leads to bone destruction in skeletal diseases such as osteoporosis, rheumatoid arthritis and cancer metastases in bone. A family of signaling enzymes known as phosphatidylinositol 3-kinases (PI3Ks) control diverse cell functions but, up until now, little was known about the function of specific PI3K isoforms in osteoclasts.

A paper published in the December 6 issue of The Journal of Biological Chemistry announces the characterization of a new potent and selective PI3Kdelta inhibitor, GS-9820. The discovery was made by members of Western University's Bone and Joint Initiative with collaborators from Nihon University, the University of Calgary and Gilead Sciences, Inc.

Graduate student Ryan Shugg, working under the supervision of Stephen Sims, PhD, and Jeff Dixon, PhD, of Western's Department of Physiology and Pharmacology, used a panel of isoform-selective inhibitors and found that one isoform in particular, PI3Kdelta, regulates osteoclast shape and resorptive activity.

Sims says, "These findings suggest that selective inhibition of PI3K isoforms offers a new approach for the treatment of inflammatory bone diseases and skeletal metastases."

The studies were carried out by an interdisciplinary team, which included undergraduate student Ashley Thomson, visiting professor Natsuko Tanabe, research scientist Alexey Pereverzev, investigator Frank Jirik at the McCaig Institute for Bone and Joint Health (University of Calgary), along with researchers Adam Kashishian, Bart Steiner, Kamal Puri, and Brian Lannutti from Gilead Sciences.

"Collaboration among researchers at Gilead Sciences, Western, Calgary and Nihon Universities was critical for accessing and testing this novel inhibitor" says Sims. "Such partnerships are essential for translating progress in fundamental cell biology into therapeutic advances."
-end-
These studies were funded in part by grants from the Canadian Institutes of Health Research (CIHR) and the Alberta Cancer Foundation. Shugg is the recipient of a Frederick Banting and Charles Best Canada Graduate Scholarship from the CIHR. Link to the paper on PubMed: http://www.ncbi.nlm.nih.gov/pubmed/24133210

University of Western Ontario

Related Bone Articles from Brightsurf:

Perforated bone tissue from too little sugar
Bone marrow cancer is currently an incurable disease that affects about 400 people in Norway every year.

Buzzing to rebuild broken bone
Healing broken bones could get easier with a device that provides both a scaffold for the bone to grow on and electrical stimulation to urge it forward, UConn engineers report.

Self-healing bone cement
Material scientists at the University of Jena have developed a bone replacement based on calcium phosphate cement and reinforced with carbon fibers.

Down to the bone: Understanding how bone-dissolving cells are generated
Bone-dissolving cells called osteoclasts are derived from a type of immune cells called macrophages.

Bone particles in blood
A researcher at The University of Texas at Arlington has found that blood vessels within bone marrow may progressively convert into bone with advancing age.

'Bone in a dish' opens new window on cancer initiation, metastasis, bone healing
Researchers in Oregon have engineered a material that replicates human bone tissue with an unprecedented level of precision, from its microscopic crystal structure to its biological activity.

UCI team pioneers cancer treatment that targets bone metastases while sparing bone
University of California, Irvine researchers have developed and tested on mice a therapeutic treatment that uses engineered stem cells to target and kill cancer bone metastases while preserving the bone.

Replicating fetal bone growth process could help heal large bone defects
To treat large gaps in long bones, like the femur, which often can result in amputation, researched developed a process in a rodent model that partially recreates the bone growth process that occurs before birth.

3D-printed 'hyperelastic bone' may help generate new bone for skull reconstruction
Defects of the skull and facial bones can pose difficult challenges for plastic and reconstructive surgeons.

From foam to bone: Plant cellulose can pave the way for healthy bone implants
Researchers from the University of British Columbia and McMaster University have developed what could be the bone implant material of the future: an airy, foamlike substance from plant cellulose that can be injected into the body and provide scaffolding for the growth of new bone.

Read More: Bone News and Bone Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.